Doxorubicin Accord liposomal 50 mg/25 ml, Konzentrat zur Herstellung einer Infusionsdispersion
7680689610023
CH-68961
Konzentrat
Associated product:
DOXORUBICIN Accord liposomal conc perf 50 mg/25ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 339.90
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68961
- Drug name
- Doxorubicin Accord liposomal, Konzentrat zur Herstellung einer Infusionsdispersion
- Galenic form
- KOIND
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 09/01/2025
- Authorization expiration date
- 08/01/2030
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DOXORUBICIN Accord liposomal conc perf 50 mg/25ml
- Description (DE)
- DOXORUBICIN Accord liposomal Inf Konz 50 mg/25ml
- Market launch
- 09/01/2025
- Narcotic (BTM)
- No
Original drug
Adriblastin RD, Injektionspräparat
GTIN: 7680503570151
CHF 32.10
Other package sizes (1)
DOXORUBICIN Accord liposomal conc perf 20 mg/10ml
1 DUR
GTIN: 7680689610016